Balyasny Asset Management
AONC

Balyasny Asset Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Balyasny Asset Management’s Portfolio AONC Stock Details AONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-187,492
Closed -$1.88M – 3275
2022
Q4 		$1.88M Sell
187,492
-426
-0.2% -$4.23K 0.01% 1454
2022
Q3 		$1.84M Buy
187,918
+176,892
+1,604% +$1.74M 0.01% 1535
2022
Q2 		$108K Buy
+11,026
New +$108K ﹤0.01% 2272

Other funds holding AONC

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Balyasny Asset Management's AONC Position: Q1 2023 in Review

Balyasny Asset Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 187,492 shares — an estimated $1.88M sold.

Balyasny Asset Management first reported a position in AONC in Q2 2022 and held it in 3 quarters. The position peaked at $1.88M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Balyasny Asset Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 187,492 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $1.88M.
  • Balyasny Asset Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2022 and held it in 3 quarters.
  • Balyasny Asset Management's American Oncology Network, Inc. Class A Common Stock position peaked at $1.88M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.